Relief Therapeutics Holding AG (RLFTF)

[massulo52]

Covid-19 vaccine manufacturers' prices exploded. But no vaccine protects 100 percent. It therefore also needs medication against a coronavirus infection. Does that mean the rally among drug researchers? There are four promising candidates.

The world is talking about how many people it takes for herd immunity to be vaccinated. About who's on when (even with an appointment calculator) and how long the effect lasts. There is even a “threat” of a glut of vaccines.

According to the World Health Organization (WHO), there are currently 22 potential Covid-19 vaccines (as of January 22) in the crucial study phases 2/3 or 3. But regardless of the quantity and quality - there is no 100% vaccination protection - we stay with us the virus will last for several years, which is why new Covid 19 diseases will keep coming. Therefore, in the future we will not only need preventive vaccines, but also effective preparations for the treatment of those who are already infected.

Therefore, four companies are presented here that have promising treatment approaches in the fight against Covid-19. These include the German biotechs Immunic (based in New York) and InflaRx, the Israeli biopharma company Redhill and the Swiss course miracle Relief.